Market Place
Sourcing Support
Tempus Molecular Profiling Now Available via Flatiron’s OncoEMR®
12 Nov 2024 //
BUSINESSWIRE
Tempus Presents Nine Abstracts at 2024 SITC Annual Meeting
08 Nov 2024 //
BUSINESSWIRE
Tempus Launches Clinical Immune Profile Score Algorithmic Test
07 Nov 2024 //
BUSINESSWIRE
Tempus Collaborates with JW Pharmaceutical for R&D Insights
28 Oct 2024 //
BUSINESSWIRE
Avacta And Tempus Collaborate To Advance AI-Driven Drug Development
21 Oct 2024 //
GLOBENEWSWIRE
Tempus Expands Takeda Collaboration In Oncology Research
26 Sep 2024 //
BUSINESSWIRE
Tempus Announces Four Abstracts Accepted For Presentation At ESMO 2024
13 Sep 2024 //
BUSINESSWIRE
BerGenBio Collaborates With Tempus To Accelerate STK11m NSCLC Development
20 Aug 2024 //
PR NEWSWIRE
CMS Awards Tempus ADLT Status For xT CDx Test
02 Jul 2024 //
BUSINESSWIRE
SoftBank Group launches AI healthcare joint venture with Tempus AI
27 Jun 2024 //
REUTERS
Tempus Introduces New HER2 & FOLR1 Testing For Personalized Care
02 Jun 2024 //
BUSINESSWIRE
Tempus Releases New Data at AACR
08 Apr 2024 //
BUSINESSWIRE
Tempus Announces Abstracts Accepted For Presentation at the AACR
05 Apr 2024 //
BUSINESSWIRE
Tempus Announces the GEMINI Non-Small Cell Lung Cancer Study
12 Jul 2023 //
BUSINESSWIRE
Tempus Announces Companion Diagnostic Collaboration with TScan Therapeutics
06 Jul 2023 //
BUSINESSWIRE
Tempus Announces Dr. Ned Sharpless as a Senior Strategic Advisor
10 May 2023 //
BUSINESSWIRE
Tempus clocks FDA approval for 648-gene cancer test
08 May 2023 //
FIERCE BIOTECH
Tempus founders build a drug discovery startup, Pathos AI, with $40M in sight
03 Mar 2023 //
ENDPTS
Tempus Announces New Strategic Collaboration with Pfizer
28 Feb 2023 //
BUSINESSWIRE
Tempus Announces Prospective Study for Biomarker Discovery in SCLC
05 Jan 2023 //
BUSINESSWIRE
Tempus Announces Data-Driven Program to Accelerate Precision Oncology Research
27 Oct 2022 //
BUSINESSWIRE
GSK announces expanded collaboration with Tempus in precision medicine
19 Oct 2022 //
PRESS RELEASE
Tempus Announces Companion Diagnostic Collaboration with Kartos Therapeutics
06 Oct 2022 //
BUSINESSWIRE
Tempus Launches Psychiatric Real-World Data Program for Personalized Medicine
20 May 2022 //
BUSINESSWIRE
Tempus’ EDGE Platform Leverages Data & AI to Identify Therapeutic Options
21 Mar 2022 //
BUSINESSWIRE
Kinnate Biopharma Presents Data from its Real-World Clinico-Genomic Study
07 Mar 2022 //
GLOBENEWSWIRE
Tempus Announces the Acquisition of Highline Sciences
08 Feb 2022 //
BUSINESSWIRE
Tempus & GSK Collborate to Begin Open Enrollment for Study of Niraparib
13 Jan 2022 //
BUSINESSWIRE
Janssen taps Tempus` AI for cancer drug discovery
02 Dec 2021 //
FIERCEBIOTECH
Tempus, AstraZeneca Collaborate to Advance Oncology Therapeutics
19 Nov 2021 //
BUSINESSWIRE
Tempus Introduces Diagnostic Test to Its Growing Collection of Algorithms
26 Oct 2021 //
BIOSPACE
Tempus Announces Companion Diagnostic Collaboration With A2 Biotherapeutics
13 Jan 2021 //
BUSINESSWIRE
